世界の埋め込み型注入ポンプ市場:医療機器パイプライン分析2016

◆英語タイトル:Implantable Infusion Pumps - Medical Devices Pipeline Assessment, 2016
◆商品コード:GDME0195EPD
◆発行会社(調査会社):GlobalData
◆発行日:2016年6月1日
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥277,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥555,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥832,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、埋め込み型注入ポンプのグローバル製品パイプライン動向について調査・分析し、以下の構成でお届けいたします。
・埋め込み型注入ポンプの概要
・埋め込み型注入ポンプの開発動向:開発段階別分析
・埋め込み型注入ポンプの開発動向:セグメント別分析
・埋め込み型注入ポンプの開発動向:領域別分析
・埋め込み型注入ポンプの開発動向:規制Path別分析
・埋め込み型注入ポンプの開発動向:承認日(推定)別分析
・企業別埋め込み型注入ポンプの開発動向(パイプライン製品、進行中の治験)
・埋め込み型注入ポンプの最近動向
【レポートの概要】

Implantable Infusion Pumps – Medical Devices Pipeline Assessment, 2016

Summary

GlobalData’s Medical Devices sector report, “Implantable Infusion Pumps – Medical Devices Pipeline Assessment, 2016″ provides an overview of Implantable Infusion Pumps currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Implantable Infusion Pumps pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Implantable Infusion Pumps under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Implantable Infusion Pumps and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Implantable Infusion Pumps under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 4
2 Introduction 5
2.1 Implantable Infusion Pumps Overview 5
3 Products under Development 6
3.1 Implantable Infusion Pumps – Pipeline Products by Stage of Development 6
3.2 Implantable Infusion Pumps – Pipeline Products by Territory 7
3.3 Implantable Infusion Pumps – Pipeline Products by Regulatory Path 8
3.4 Implantable Infusion Pumps – Pipeline Products by Estimated Approval Date 9
4 Implantable Infusion Pumps – Pipeline Products under Development by Companies 10
4.1 Implantable Infusion Pumps Companies – Pipeline Products by Stage of Development 10
4.2 Implantable Infusion Pumps – Pipeline Products by Stage of Development 11
5 Implantable Infusion Pumps Companies and Product Overview 12
5.1 Alnylam Pharmaceuticals, Inc. Company Overview 12
5.1.1 Alnylam Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 12
5.2 Debiotech S.A. Company Overview 14
5.2.1 Debiotech S.A. Pipeline Products & Ongoing Clinical Trials Overview 14
5.3 Delpor, Inc. Company Overview 16
5.3.1 Delpor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 16
5.4 Eksigent Technologies, LLC Company Overview 18
5.4.1 Eksigent Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 18
5.5 Eli Lilly and Company Company Overview 19
5.5.1 Eli Lilly and Company Pipeline Products & Ongoing Clinical Trials Overview 19
5.6 Flowonix Medical, Inc. Company Overview 21
5.6.1 Flowonix Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
5.7 FluidSynchrony, LLC Company Overview 22
5.7.1 FluidSynchrony, LLC Pipeline Products & Ongoing Clinical Trials Overview 22
5.8 Intarcia Therapeutics, Inc. Company Overview 23
5.8.1 Intarcia Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
5.9 Medallion Therapeutics, Inc. Company Overview 27
5.9.1 Medallion Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
5.10 Nano Precision Medical Company Overview 28
5.10.1 Nano Precision Medical Pipeline Products & Ongoing Clinical Trials Overview 28
5.11 Pharmaco-Kinesis Corporation Company Overview 29
5.11.1 Pharmaco-Kinesis Corporation Pipeline Products & Ongoing Clinical Trials Overview 29
5.12 University of Minnesota Company Overview 31
5.12.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 31
5.13 University of Southern California Company Overview 33
5.13.1 University of Southern California Pipeline Products & Ongoing Clinical Trials Overview 33
6 Implantable Infusion Pumps- Recent Developments 34
6.1 May 18, 2016: Flowonix Medical Appoints Larry Heaton as CEO 34
6.2 May 11, 2016: Teleflex Raises USD400 Million in Public Offering of 4.875% Notes Due 2026 34
6.3 May 06, 2016: Intarcia Announces Successful Cardiovascular Safety Results in Phase 3 FREEDOM-CVO Trial for ITCA 650, an Investigational Therapy for Type 2 Diabetes 35
6.4 Nov 02, 2015: Flowonix Medical and Connecticut Pain Care Announce the First Implant of the Prometra II Pump in Danbury, CT 36
7 Appendix 38
7.1 Methodology 38
7.2 About GlobalData 40
7.3 Contact Us 41
7.4 Disclaimer 41

1.1 List of Tables
Table 1: Implantable Infusion Pumps - Pipeline Products by Stage of Development 6
Table 2: Implantable Infusion Pumps - Pipeline Products by Territory 7
Table 3: Implantable Infusion Pumps - Pipeline Products by Regulatory Path 8
Table 4: Implantable Infusion Pumps - Pipeline Products by Estimated Approval Date 9
Table 5: Implantable Infusion Pumps Companies - Pipeline Products by Stage of Development 10
Table 6: Implantable Infusion Pumps - Pipeline Products by Stage of Development 11
Table 7: Alnylam Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 12
Table 8: ALN-HTT Infusion System - Product Status 12
Table 9: ALN-HTT Infusion System - Product Description 13
Table 10: Debiotech S.A. Pipeline Products & Ongoing Clinical Trials Overview 14
Table 11: MIP Device - Product Status 14
Table 12: MIP Device - Product Description 15
Table 13: Delpor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 16
Table 14: Delpor Microfabricated Nanopore Device - Product Status 16
Table 15: Delpor Microfabricated Nanopore Device - Product Description 17
Table 16: Eksigent Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 18
Table 17: Implantable Drug Delivery System - Product Status 18
Table 18: Implantable Drug Delivery System - Product Description 18
Table 19: Eli Lilly and Company Pipeline Products & Ongoing Clinical Trials Overview 19
Table 20: Drug Delivery System - Parkinson's Disease - Product Status 19
Table 21: Drug Delivery System - Parkinson's Disease - Product Description 20
Table 22: Flowonix Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
Table 23: Implanted Drug Delivery System - Product Status 21
Table 24: Implanted Drug Delivery System - Product Description 21
Table 25: FluidSynchrony, LLC Pipeline Products & Ongoing Clinical Trials Overview 22
Table 26: FluidSync Pump - Product Status 22
Table 27: FluidSync Pump - Product Description 22
Table 28: Intarcia Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
Table 29: ITCA 638 - Product Status 23
Table 30: ITCA 638 - Product Description 24
Table 31: ITCA 650 Osmotic Pump - Product Status 24
Table 32: ITCA 650 Osmotic Pump - Product Description 25
Table 33: ITCA 880 - Product Status 25
Table 34: ITCA 880 - Product Description 26
Table 35: Medallion Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
Table 36: Medallion Infusion System - Product Status 27
Table 37: Medallion Infusion System - Product Description 27
Table 38: Nano Precision Medical Pipeline Products & Ongoing Clinical Trials Overview 28
Table 39: Nano Portal Capsule - Product Status 28
Table 40: Nano Portal Capsule - Product Description 28
Table 41: Pharmaco-Kinesis Corporation Pipeline Products & Ongoing Clinical Trials Overview 29
Table 42: Second Generation Metronomic Biofeedback Pump - Product Status 29
Table 43: Second Generation Metronomic Biofeedback Pump - Product Description 30
Table 44: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 31
Table 45: Infusion Micropump - Product Status 31
Table 46: Infusion Micropump - Product Description 32
Table 47: University of Southern California Pipeline Products & Ongoing Clinical Trials Overview 33
Table 48: Drug Infusion Pump - Product Status 33
Table 49: Drug Infusion Pump - Product Description 33
Table 50: Glossary 39

1.2 List of Figures
Figure 1: Implantable Infusion Pumps - Pipeline Products by Stage of Development 6
Figure 2: Implantable Infusion Pumps - Pipeline Products by Territory 7
Figure 3: Implantable Infusion Pumps - Pipeline Products by Regulatory Path 8
Figure 4: Implantable Infusion Pumps - Pipeline Products by Estimated Approval Date 9

【掲載企業】

Alnylam Pharmaceuticals, Inc.
Debiotech S.A.
Delpor, Inc.
Eksigent Technologies, LLC
Eli Lilly and Company
Flowonix Medical, Inc.
FluidSynchrony, LLC
Intarcia Therapeutics, Inc.
Medallion Therapeutics, Inc.
Nano Precision Medical
Pharmaco-Kinesis Corporation
University of Minnesota
University of Southern California

★調査レポート[世界の埋め込み型注入ポンプ市場:医療機器パイプライン分析2016]販売に関する免責事項
★調査レポート[世界の埋め込み型注入ポンプ市場:医療機器パイプライン分析2016]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆